Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves
Open Access
- 29 May 2017
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 69 (22), 2681-2691
- https://doi.org/10.1016/j.jacc.2017.03.605
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)European Heart Journal, 2011
- A Prospective Trial Showing the Safety of Adjusted-Dose Enoxaparin for Thromboprophylaxis of Pregnant Women With Mechanical Prosthetic Heart ValvesClinical and Applied Thrombosis/hemostasis, 2010
- Use of Low Molecular Weight Heparin in Pregnant Women With Mechanical Heart ValvesThe American Journal of Cardiology, 2009
- Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experienceHaematologica, 2009
- Pregnancy outcome in women with prosthetic heart valvesAmerican Journal of Obstetrics and Gynecology, 2004
- Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prosthesesThe American Journal of Cardiology, 1989
- Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart ValvesNew England Journal of Medicine, 1986
- Long-term results of tricuspid valve replacement and the problem of prosthetic valve thrombosisThe American Journal of Cardiology, 1983
- Late Thrombotic Malfunction of the Björk–Shiley Tilting Disc Valve in the Tricuspid Position.Principles for Recognition and ManagementScandinavian Journal of Thoracic and Cardiovascular Surgery, 1980
- Transformations Related to the Angular and the Square RootThe Annals of Mathematical Statistics, 1950